Glow (GHK-Cu + TB-500 + BPC-157)
A skin-and-recovery research blend combining the copper peptide GHK-Cu with TB-500 and BPC-157, marketed for skin quality and tissue repair. GHK-Cu has human cosmetic data; the other two are animal-only, and the combination is untested.
In plain English
'Glow' bundles three peptides aimed at skin and recovery: GHK-Cu (a copper-binding tripeptide with real cosmetic/skin data), plus the two 'Wolverine' recovery peptides TB-500 and BPC-157. The marketing angle is better skin, faster healing, and an overall 'glow.' GHK-Cu genuinely has supportive human cosmetic and mechanistic evidence, but the injectable systemic use in this blend is different from the topical use that was studied. TB-500 and BPC-157 remain animal-only and unapproved (TB-500 is WADA-banned), and the three-peptide combination has never been tested in any study.
What it is
A combination of GHK-Cu (glycyl-L-histidyl-L-lysine copper complex, a tripeptide used in skincare), TB-500 (thymosin beta-4 fragment), and BPC-157 (gastric-derived pentadecapeptide). Sold as a skin/recovery 'glow' stack. None is an FDA-approved drug for this use.
Mechanism (summary)
GHK-Cu modulates skin-regeneration pathways, stimulates collagen and extracellular-matrix synthesis, and has antioxidant and wound-supportive activity (well documented for topical use). TB-500 contributes actin-binding/cell-migration effects and BPC-157 contributes angiogenic/growth-factor effects from their animal literatures. The blend is intended to pair skin remodeling with tissue repair, but the combined and systemic-injection effects are not characterized in controlled studies.
Why people research it
- Skin quality, collagen support, and cosmetic 'glow'
- Wound and soft-tissue healing
- Combined skin-and-recovery use
- Anti-aging skin remodeling
Human evidence
There are no human trials of the GHK-Cu + TB-500 + BPC-157 combination. GHK-Cu individually has supportive human cosmetic/observational evidence — but for topical skincare, not the injected systemic use implied by this blend. TB-500 and BPC-157 have no human RCTs and only animal data. The combination's claims are therefore extrapolation, strongest for the GHK-Cu cosmetic component and weakest for the systemic recovery components.
Animal / lab evidence
GHK-Cu shows wound-healing and matrix-remodeling effects in animal and mechanistic studies; TB-500 / thymosin beta-4 supports wound healing and cell migration in animals; BPC-157 accelerates connective-tissue and gut healing in rodents. No animal study tests this three-peptide blend together.
Key studies
Each summary explains the design, what was found, and what it doesn't prove.
Real human evidence — but for GHK applied to the skin, not injected, and not in this stack.
Lab-dish evidence for the TB-500 component's role in healing; not proof for the blend.
Animal-level support for the BPC-157 component only.
History
'Glow' protocols arose in peptide clinics and biohacking communities pairing the established cosmetic peptide GHK-Cu with the popular recovery duo TB-500 and BPC-157, marketed for combined skin and healing benefits without combination evidence.
PeptidePedia is for educational and informational purposes only. We do not sell peptides, prescribe peptides, provide medical advice, or recommend treatment. Peptides may not be approved for human use except in specific legal prescription or clinical contexts. Always consult a licensed medical professional before making health decisions.
Related peptides
A naturally occurring copper-binding tripeptide widely used in cosmetics and studied for skin remodeling and wound healing.
A synthetic fragment of thymosin beta-4 studied in animals for wound healing, cardiac repair, and tissue regeneration.
A 15-amino-acid fragment derived from a stomach-protecting protein, widely studied in rodents for gut, tendon, and ligament repair.
The C-terminal tripeptide of α-MSH studied for anti-inflammatory effects in gut and skin disease.